elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36697070-1F2E5AE3-DBA0-4C9A-B8F0-83D43012A69E
Q36697070-1F2E5AE3-DBA0-4C9A-B8F0-83D43012A69E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36697070-1F2E5AE3-DBA0-4C9A-B8F0-83D43012A69E
The effect of antagonizing RGD-binding integrin activity in papillary thyroid cancer cell lines
P2860
Q36697070-1F2E5AE3-DBA0-4C9A-B8F0-83D43012A69E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36697070-1F2E5AE3-DBA0-4C9A-B8F0-83D43012A69E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d8a5c2316cd7754e201e574687693532b05be6b2
P2860
Cilengitide: an RGD pentapeptide ανβ3 and ανβ5 integrin inhibitor in development for glioblastoma and other malignancies.